SCHEMBL13562791

SCHEMBL13562791

COc1cc(O)cc(/C=c2\[nH]c(=O)/c(=C/c3ncoc3C(C)(C)C)[nH]c2=O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ RAF1 P04049 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ CCNB1 P14635 1/20 0.38
▸ PIK3CG P48736 1/20 0.38
▸ SERPINE1 P05121 2/20 0.38
▸ CYP2D6 P10635 1/20 0.35
▸ EGFR P00533 2/20 0.35
▸ BACE1 P56817 1/20 0.34
▸ PTGS2 P35354 3/20 0.33
▸ TTR P02766 1/20 0.33
▸ CYP1A1 P04798 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ CYP1B1 Q16678 1/20 0.33
▸ TUBB4A P04350 2/20 0.33
▸ TUBB P07437 2/20 0.33
▸ TUBA3C P0DPH7 2/20 0.33
▸ TUBA1B P68363 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL79702 0.94 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19RAF1CDK1
SCHEMBL87443 0.94 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19RAF1CDK1
SCHEMBL87290 0.86 SERPINE1 (0.45) CYP1A2CYP2C9CYP2C19RAF1CDK1
SCHEMBL79107 0.86 SERPINE1 (0.45) CYP1A2CYP2C9CYP2C19RAF1CDK1
SCHEMBL91422 0.83 CYP1A2 (0.46) CYP1A2CYP2C9CYP2C19RAF1CDK1
SCHEMBL79112 0.82 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19RAF1CDK1
SCHEMBL88264 0.82 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19RAF1CDK1
SCHEMBL79478 0.78 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19RAF1CDK1
SCHEMBL87420 0.78 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19RAF1CDK1
SCHEMBL79694 0.78 CYP1A2 (0.48) CYP1A2CYP2C9CYP2C19RAF1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120277251-A1 ANALOGS OF DEHYDROPHENYLAHISTINS AND THEIR THERAPEUTIC USE NEREUS PHARMACEUTICALS, INC. (US) 2012-11-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120277251-A1 ANALOGS OF DEHYDROPHENYLAHISTINS AND THEIR THERAPEUTIC USE MKI67, HPGDS, HCCS CYP1A2 2042/4885CYP2C9 4257/4885CYP2C19 3184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback